Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bodø
Clinical trial register · Norway

Clinical Trials in Bodø, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Norway and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1259 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
1259
Studies in scope
all four open statuses
666
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
Oslo 727 Bergen 323 Trondheim 255 Tromsø 148 Stavanger 123
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Nordlandssykehuset HF6 Haukeland University Hospital4 AstraZeneca4 Oslo University Hospital4 Merck Sharp & Dohme LLC3 Diakonhjemmet Hospital2 Sykehuset Telemark2 University Hospital, Akershus1 Alfasigma S.p.A.1 Sorlandet Hospital HF1 Viatris Innovation GmbH1 Eikon Therapeutics1 Ostfold Hospital Trust1 Bristol-Myers Squibb1 Region Skane1 St. Olavs Hospital1 Boehringer Ingelheim1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Danish Breast Cancer Cooperative Group1 Sanofi1 University Hospital of North Norway1
Site location
Oslo727 Bergen323 Trondheim255 Tromsø148 Stavanger123 Lørenskog101 Drammen94 Kristiansand58 Ålesund56 Bodø38 Tønsberg35 Grålum32 Lorenskog26 Arendal26 Haugesund24 Gjøvik24 Skien22 Levanger22 Lillehammer17 Førde16 Sarpsborg15 Hamar14 Nordbyhagen12 Fredrikstad11 Molde11 Sandvika8 Namsos8 Kristiansund8 Gjettum7 Moss6 Halden5 Skedsmokorset5 Sandnessjøen5 Brumunddal4 Volda4 Vikersund4 Kongsberg4 Haukeland4 Sandnes4 Alta4 Hagavik4 Narvik3 Harstad3 Hjelset3 Multiple Locations3 Nesoddtangen3 Elverum3 Ottestad3 Innlandet3 Nydalen3 Lillestrøm3 Hønefoss3 Asker3 Notodden2 Strømmen2 Skjetten2 Orkanger2 Many Locations2 Straume2 Ås2 Loerenskog2 Mo i Rana2 Leknes2 Bærums verk2 Troms2 Lrenskog2 Kirkenes2 Florø1 Indre Østfold1 Nittedal1 Ski1 Lörenskog1 Tynset1 Akershus1 Voss1 Os i Østerdalen1 Nordbyagen1 Askøy1 Lyngseidet1 Eina1 Baerum1 Tromsø1 Sogneprest Munthe-kaas Vei 1001 Fyllingsdalen1 Isdalstø1 Olsvik1 Borre1 Bømlo1 Bærum1 Ål1 Hågån1 Brekstad1 Kopervik1 Rud1 Sandefjord1 Eiken1 Evje1 Flekke1 Hernes1 Orkdal1 Birkeland1 Jessheim1 Kløfta1 Brandbu1 Lena1 Askim1 Bjørkelangen1 Bodø1 Norway1 Farsund1 Nordlenangen1 Kalnes1 Rissa1
All 113 locations
Target enrolment
to

Trials with a site in Bodø

39 of 1259 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Norway
Start
Not yet open
University Hospital of North Norway
Not applicable
140
Bodø, Tromsø
2026-12-01
By invitation
Nordlandssykehuset HF
Observational
60
Bodø
2026-11-05
Recruiting
AstraZeneca
Phase 3
7,000
Bergen, Bodø, Drammen, Grålum, Haugesund, Levanger, Lørenskog, Oslo
2026-08-21
Recruiting
University Hospital, Akershus
Phase 4
1,900
Bergen, Oslo, Trondheim, Ålesund, Bodø, Drammen, Gjettum, Grålum
2026-04-23
Recruiting
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
NCT07312110Parkinson s Disease, Parkinson Disease (PD)
Haukeland University Hospital
Phase 2
100
Arendal, Lørenskog, Drammen, Molde, Bodø, Oslo, Haugesund, Tromsø
2026-01-20
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Arendal, Bodø, Drammen, Grålum, Lørenskog, Oslo, Skedsmokorset, Stavanger
2025-07-22
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Lørenskog, Drammen, Bodø, Stavanger
2025-06-30
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Bodø, Grålum, Oslo, Trondheim
2025-06-10
Recruiting
Eikon Therapeutics
Phase 2/3
740
Bodø, Oslo, Drammen
2025-05-22
Recruiting
The Norwegian Immunotherapy in Multiple Myeloma Study
NCT06855121Myeloma Multiple, Plasma Cell Leukemia, AL Amyloidosis
DrugsIdecabtagene vicleucel·Talquetamab·Elranatamab·Teclistamab
St. Olavs Hospital
Observational
400
Arendal, Ålesund, Bergen, Bodø, Bærum, Drammen, Førde, Gjøvik
2025-01-15
Recruiting
Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors
NCT06398314Gastrointestinal Cancer, Urologic Cancer, Gynecologic Cancer
Sykehuset Telemark
Not applicable
200
Ålesund, Bergen, Bodø, Drammen, Gjøvik, Kristiansand, Oslo, Skien
2024-12-10
Recruiting
The Benefit of Repairing the Deltoid Ligament in Unstable Ankle Fractures
NCT06568276Ankle Fractures, Deltoid Ligament; Sprain (Strain) (Ankle)
Ostfold Hospital Trust
Not applicable
120
Grålum, Ålesund, Bergen, Bodø, Elverum, Gjøvik, Levanger, Oslo
2024-09-20
Active, closed
Diakonhjemmet Hospital
Phase 4
387
Oslo, Ålesund, Bergen, Bodø, Drammen, Førde, Haugesund, Kristiansand
2024-08-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Bodø, Oslo
2024-08-05
Recruiting
Safer Personalised Cancer Treatment Digital Follow-up
NCT06476158Patient Reported Outcome Measure
Nordlandssykehuset HF
Not applicable
900
Bodø
2024-06-01
Active, closed
Nordlandssykehuset HF
Not applicable
114
Bodø
2024-03-04
Recruiting
Nordlandssykehuset HF
Not applicable
50
Bodø
2024-01-27
Active, closed
AstraZeneca
Phase 3
1,835
Bodø, Lørenskog, Oslo, Stavanger, Tromsø
2023-11-07
Active, closed
Diakonhjemmet Hospital
Phase 4
354
Bodø, Haugesund, Oslo, Sandvika, Stavanger, Trondheim
2023-11-03
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Bodø, Drammen, Kristiansand, Skien, Tromsø
2023-10-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Lorenskog, Bergen, Ålesund, Bodø, Lillehammer, Oslo
2023-10-09
Active, closed
Alfasigma S.p.A.
Observational
509
Bodø, Lørenskog, Oslo, Tromsø, Trondheim
2023-06-12
Recruiting
Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families
NCT05744310Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Nervous System Diseases, Spinal Cord Diseases
Haukeland University Hospital
Not applicable
200
Bodø, Kristiansand, Bergen, Lørenskog, Oslo, Sarpsborg, Stavanger, Tromsø
2023-04-21
Recruiting
Region Skane
Not applicable
1,350
Ålesund, Bergen, Bodø, Gjøvik, Kristiansand, Oslo, Stavanger, Tromsø
2023-03-17
Active, closed
Bristol-Myers Squibb
Phase 3
579
Bodø, Grålum, Lørenskog, Oslo
2023-03-06
Active, closed
A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service. The NSAC Efficacy Study
NCT05310695Musculoskeletal Disorder, Anxiety Disorders, Depression, Fatigue
Nordlandssykehuset HF
Not applicable
2,500
Bodø, Sandnessjøen, Alta, Kirkenes, Tromsø
2023-01-16
Active, closed
AstraZeneca
Phase 3
791
Bodø, Gjøvik, Oslo, Trondheim
2022-02-18
Active, closed
Haukeland University Hospital
Not applicable
300
Bergen, Bodø, Drammen, Førde, Haugesund, Kristiansand, Lillehammer, Lørenskog
2021-10-07
Active, closed
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
NCT05006976Musculoskeletal Disorder, Anxiety Disorders, Depression, Fatigue
Nordlandssykehuset HF
Not applicable
1,180
Bodø, Sandnessjøen, Alta, Kirkenes, Tromsø
2021-09-06
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Arendal, Ålesund, Bodø, Lørenskog, Oslo, Sarpsborg, Stavanger, Tønsberg
2021-08-14
Active, closed
Sorlandet Hospital HF
Not applicable
205
Arendal, Bergen, Bodø, Oslo, Trondheim
2021-05-15
Recruiting
Oslo University Hospital
Phase 2
3,000
Ålesund, Bergen, Bodø, Drammen, Førde, Hamar, Haugesund, Kristiansand
2021-04-01
Active, closed
Haukeland University Hospital
Phase 3
214
Bergen, Bodø, Drammen, Kristiansand, Molde, Namsos, Oslo, Skien
2020-11-02
Recruiting
Oslo University Hospital
Phase 2/3
176
Ålesund, Bergen, Bodø, Fredrikstad, Førde, Kristiansand, Levanger, Lørenskog
2020-08-27
Recruiting
Genetic Study of Amyotrophic Lateral Sclerosis in Norway
NCT05119387Amyotrophic Lateral Sclerosis
Sykehuset Telemark
Observational
1,200
Bergen, Bodø, Drammen, Førde, Grålum, Haugesund, Kristiansand, Lillehammer
2019-08-01
Active, closed
Sanofi
Observational
955
Bergen, Bodø
2019-06-11
Active, closed
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
NCT03646357Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction
DrugBetablocker
Oslo University Hospital
Phase 4
2,895
Arendal, Bergen, Bodø, Drammen, Fredrikstad, Gjøvik, Hamar, Hønefoss
2018-10-01
Recruiting
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
NCT03646955Local Neoplasm Recurrence, Distantly Metastatic Malignant Neoplasm, Death, Fibrosis Breast
Danish Breast Cancer Cooperative Group
Not applicable
926
Bergen, Bodø, Kristiansand, Oslo, Stavanger, Tromsø
2018-09-05
Active, closed
Oslo University Hospital
Phase 4
150
Ålesund, Bergen, Bodø, Kristiansand, Oslo, Stavanger, Tromsø, Trondheim
2014-01
Rows per page Showing 1–39 of 39
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Norwegian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-norway/city/bod

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Norway and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,259 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 39 of those studies with a site in Bodø.

How many clinical trials are recruiting in Bodø?

18 of the 39 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 18 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bodø), 39 studies
PhaseStudiesRecruitingShare
Not applicable13733.3%
Phase 311328.2%
Observational6315.4%
Phase 45112.8%
Phase 2225.1%
Phase 2/3225.1%

Most active sponsors

Lead sponsors with the most studies (Bodø)
Lead sponsorStudiesRecruiting
Nordlandssykehuset HF62
AstraZeneca41
Haukeland University Hospital42
Oslo University Hospital42
Merck Sharp & Dohme LLC31
Diakonhjemmet Hospital20
Sykehuset Telemark22
Alfasigma S.p.A.10
Boehringer Ingelheim11
Bristol-Myers Squibb10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.